Media Mind just completed its annual survey of healthcare journalists, tallying their thoughts and views on pharmaceutical companies, insurers, agencies, and medical centers.
MS&L has appointed Peter Harris to director of its corporate practice in North America, and Renee Wilson to managing director of its New York office.
In today's trust-bereft marketplace, it's engagement that people crave, and engagement that builds trust.
Porter Novelli has hired Anthony Viceroy as president of global business operations and chief financial officer. Viceroy will report to Gary Stockman, the agency's CEO.
WeissComm has announced the acquisition of ODA, a San Francisco-based creative shop focused on healthcare brands.
CNN's sacking some of its most experienced science journalists and producers could not come at a worse time.
Sanofi-Aventis launched a community health partnership in Baltimore, in response to disturbing health trends among African-Americans there.
Hoping to address PR needs in light of shrinking budgets, Shannon Troughton has launched VoxPop Public Relations, in Indianapolis.
Signs of wrenching change for the industry were unmistakable even before the economic crisis.
During a period of economic instability, consumers tend to focus on day-to-day life, rather than considering the long view.
Medical device and surgical manufacturer Covidien has launched a website to educate patients and physicians on the benefits of bariatric surgery as a treatment for Type 2 diabetes.
Nearly five years after the human genome was decoded, the age of genetics is finally upon us; "personalized medicine" has arrived.
Porter Novelli's Washington, DC, office landed a multimillion dollar contract from the Centers for Medicare and Medicaid Services (CMS).
Johnson & Johnson (J&J) has announced a restructuring of its public affairs and corporate communications team.
As a company that focuses on healthcare PR, we are often involved in early-stage product communications.
Senetek PLC, a life sciences company focused on anti-aging technologies, has tapped Michael Rogers PR for the launch of its Pyratine-6 product.
Fleishman-Hillard has won an AOR assignment for Siemens Medical System's AG's global health division.
This year has not been kind to biopharmaceutical companies.
Bayer Diabetes Care has partnered with Nick Jonas for a campaign urging young people to proactively manage diabetes.
Joseph Wenke, partner and creative director at Xperience Communications, says bringing marketing principles into discussions with doctors makes sense.
Let's be clear. As one who has spent half a life working in the increasingly regulated "pay for what you get" advertising side of the communication business, I have regarded PR as something of an uncertain universe.
Responding to the billions of dollars in industry fines paid under the False Claims Act, the Center for Communication Compliance (CCC) launched a new online compliance portal.
Cohn & Wolfe has launched GCI Health, a global public relations firm.
When pharmaceutical companies choose to maintain a favorable and high-profile media presence, the benefits are commercially advantageous, with measurable corporate, investor and marketing and sales impact.
In a study conducted by public relations agency Ketchum, researchers uncovered a variety of factors that pinpoint the way consumers make decisions about healthcare.
WellPoint, a national health benefits provider, named Ricochet Public Relations as its first agency of record. Duties
Whenever the subject of healthcare and new media comes up, the refrain is almost always: "we're way behind."
Websites aren't the only thing to consider when employing search engine optimization (SEO), according to PR practitioners and service providers.
Burson-Marsteller has appointed Gail Cohen to global chair of the firm's healthcare practice.
The question of public relations versus other marketing spends is probably a debate that never will go quietly into the night.
Voluminous press coverage over cholesterol drug safety have led to a study measuring consumer perception.
WeissComm Partners has promoted Diane Weiser to the position of president and chief operating officer.
The conventional wisdom is that uncertainty about the 2008 elections makes healthcare strategic planning difficult. Or, maybe not.
DTC ads can be "both a blessing and a curse," and if companies fail to include messaging about patient assistance programs in them, "then your message is a resentful one."
Centocor launched itself into the blogosphere with the debut of its corporate blog at cnto411.com.
Go online and you'll see bountiful commentary about drug companies and their products.
Lilly took a sharp tone in responding to a New York Times article that the company said "likely created a strong false impression with readers that Lilly suppresses data."
Wyeth hired Timothy Cost to head its corporate affairs department, replacing Marily Rhudy, who is retiring.
When choosing a celebrity product spokesperson in the scrutinized world of pharmaceutical communications, it's essential that great care and consideration is put into the selection.
It's a reflection of our times: if you're in healthcare you must also have political smarts.
Two top pharmas looked outside the industry for their top communications executives
Bowing to outraged patient advocates, NYU Child Study Center said it will halt its controversial print and outdoor ads aimed at raising awareness of mental health problems in kids.
The consumer has arrived in health.
Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, generated some unwelcome publicity when he lashed out at a 17-year-old intern from a Savannah, GA, newspaper at a November event for the patient assistance program.
MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.
Treating rare disorders was once considered a "good-will science endeavor," but market forces have encouraged companies to revisit how these small molecules can be big business, and researchers are finding that therapeutic applications for one rare disease area often holds promise in others.
Pfizer and Nektar have buried the hatchet after the former paid the latter $135 million following its abrupt decision to discontinue marketing of Exubera, on which the two firms partnered.
Novartis is experimenting with blogging for physicians with melanomaperspectives.com.
Keeping up with new communication technologies and online trends is a critical bar for entry in our business.
Sanofi-Aventis is partnering with four major cancer patient groups and Wachovia to produce a star-studded series of events aimed at raising awareness of women's cancers.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.